4.7 Article

Anti-obesity and hypolipidemic effects ofFuzhuan brick tea water extract in high-fat diet-induced obese rats

期刊

JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
卷 93, 期 6, 页码 1310-1316

出版社

WILEY
DOI: 10.1002/jsfa.5887

关键词

Fuzhuan brick tea water extract; anti-obesity; hypolipidemic; hepatic steatosis

资金

  1. Key Project of Hunan Provincial Department of Science and Technology [2008FJ1005]
  2. National Natural Science Foundation of China [31200522]
  3. Ministry of Science and Technology of China
  4. Key Project of National Technology Innovation System for Tea Industry in the People's Republic of China [CARS-23]

向作者/读者索取更多资源

Background Fuzhuan brick tea is a kind of microbial fermented tea, which has received increasing attention in recent years owing to its benefits for human health. In this study, the anti-obesity and hypolipidemic effects of Fuzhuan brick tea water extracts (FTEs) were investigated. Results FTEs consisted of 204.07 +/- 3.38 mg g1 polyphenol, 109.20 +/- 1.36 mg g1 flavonoids, and others. The FTEs significantly suppressed the increase of body weight and accumulation of adipose tissue, and reduced the level of serum triacylglycerol, total cholesterol and low-density lipoprotein (LDL) cholesterol in obese rats fed a high-fat diet. Moreover, FTEs attenuated the gene expression of sterol regulatory element binding protein-1c, fatty acid synthase and CCAAT/enhancer binding protein , which is related to lipogenic metabolism. In contrast, the gene expressions of enzymes involved in energy expenditure and lipodieresis including hepatic peroxisome proliferator-activated receptor , carnitine palmitoyltransferase 1a and LDL receptor gene expression were increased by FTE treatment. Conclusions Our study demonstrates that FTEs have anti-obesity and hypolipidemic functions, suggesting that it might be effective for treatment of obesity and hyperlipemia. (C) 2012 Society of Chemical Industry

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据